Tryton

About

Tryton Medical, Inc. is a medical device company based in Durham, North Carolina, founded in 2003. The company specializes in cardiovascular interventions, particularly focusing on developing stent systems for treating coronary bifurcation lesions. Tryton's flagship product, the Tryton Side Branch Stent, is the only FDA-approved bifurcated stent designed to be used alongside a conventional drug-eluting stent in the main vessel. This stent aims to enhance procedural efficiency and is supported by clinical studies demonstrating its effectiveness. With a strong emphasis on innovation, Tryton holds 25 patents related to stent design and implantation methods. The company has achieved significant milestones, including FDA pre-market approval in March 2017 and the initiation of commercial availability the same month. Tryton targets interventional cardiologists and hospitals, promoting its stent for use in patients with bifurcation lesions. The company continues to focus on providing specialized solutions in the advanced medical device sector.